Frequently Asked Questions
The market is segmented based on , By Type (Sydenham’s Chorea and Chorea-Acanthocytosis), Treatment (Medication, Surgeries and Others), Drugs Class (Antipsychotic Drugs and Benzodiazepines Drugs), Symptoms (Involuntary Muscle Movements, Milkmaid’s Grip, Speech Problems and Seizures), End-Users (Clinics, Hospitals, Ambulatory Surgical Centres and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others) – Industry Trends and Forecast to 2030.
.
The Global Chorea Treatment Market size was valued at USD 651.57 USD Million in 2022.
The Global Chorea Treatment Market is projected to grow at a CAGR of 5% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.
